The importance of sexual and reproductive health and rights to prevent HIV in AGYW in ESA
This WHO’s Evidence Brief highlights some of the key points of discussion during the ESA regional consultation on HIV prevention and sexual and reproductive health and rights for Adolescent Girls and Young Women (AGYW) held in Windhoek on 1-3 February. The Evidence Brief is now available here.
Global Accelerated Action for the Health of Adolescents (AA-HA!)
WHO launched in May the long-awaited Global Accelerated Action for the Health of Adolescents (AA-HA!): Guidance to Support Country Implementation. Click here for the press-release and other resources. This is a guidance to operationalize the adolescent component of the Global Strategy for Women’s, Children’s and Adolescents’ Health (2016-2020). Interestingly, this new guidance moves away from entry points for adolescent health, as HIV and SRH, to address broader adolescent health issues. Click here to access the AA-HA! guidance document.
Good Practice Guide – Adolescent HIV Programming
The International HIV/AIDS Alliance published in May 2017 a good practice guide on Adolescent HIV programming. This guide contains information, strategies and resources, including UNICEF materials, to help programmers meet good practice standards for HIV programming for adolescents. It can be used at any time in the programme cycle to assess good practice, and to help develop proposals and monitoring and evaluation frameworks. Click here to access the guide.
TB along the lifecycle: integration of TB into HIV and maternal and child health programmes
Presentations:
- TB in women, infants, children and adolescents – key data, gaps and opportunities, Steve Graham, University of Melbourne and The International Union Against TB and Lung Disease
- Addressing TB along the lifecycle – lessons from Uganda, Moorine Sekadde, National TB Programme, Uganda
- Kenya's experience providing IPT in PMTCT settings, Immaculate Kathure, National TB Programme, Kenya
2016 IATT Paediatric ARV Optimal Formulary List
Developed by the IATT in response to procurement and supply challenges resulting from fragmented demand for paediatric ARVs, and has been developing guidance around the selection of optimal products since 2011, this brief is intended for use by programme managers and policy makers and provides formulary selection and procurement guidance for the optimal paediatric ARV dosage forms needed to provide all WHO recommended 1st and 2nd line regimens while simplifying supply chain and easing administration. The brief includes both the Optimal Paediatric ARV formulary as well as the Limited Use list of those formulations that may be needed in special circumstances. As the Optimal Formulary and Limited Use lists are updated on a regular basis, explanation is provided for updates made since 2013.
POC Webinar - HIV testing in primary health care clinics
Performance of point-of-care birth HIV testing in primary health care clinics: an observational cohort study
Bindiya Meggi, MSc
Download file(s)
Point of Care - HIV Diagnosis: Bringing Faster Results for Each and More Effective Treatment
Accelerating Access and Integration of Innovative Point of Care Diagnostics for HIV in National Diagnostics Programmes